# Pharmaceutical Glycerin Based Products Market

> Pharmaceutical Glycerin Based Products Market Research Report Information by Drug Type (Dermatological, Opthalmic, Cough Remidies, Glycerine Rectal and Angina) And By Region (North America, Europe, Asia-Pacific, And Rest of the World) –Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.1%
- **2024:** $ 0.25 Billion
- **2025:** $ 0.28 Billion
- **2035:** $ 0.87 Billion
- **Key Players:** BASF SE (DE), Dow Inc. (US), Glycerin Products LLC (US), Cargill, Incorporated (US), Wilmar International Limited (SG), Kraton Corporation (US), Emery Oleochemicals (MY), Vantage Specialty Chemicals, Inc. (US)

**Report ID:** MRFR/Pharma/10633-HCR · **Pages:** 128 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/pharmaceutical-glycerin-based-products-market-12154

---

## Market Summary

## **Global Pharmaceutical Glycerin Based Products Market Overview**

As per MRFR analysis, the Pharmaceutical Glycerin Based Products Market Size was estimated at 0.25 (USD Billion) in 2024. The Pharmaceutical Glycerin Based Products Market Industry is expected to grow from 0.28 (USD Billion) in 2025 to 0.77 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 12.10% during the forecast period (2025 - 2034).
Increasing the use of glycerin to treat illnesses that cause elevated eye pressure such as glaucoma is the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Pharmaceutical Glycerin Based Products Market Trends**

The pharmaceutical and ophthalmology sectors' increased use of [glycerin](../../../reports/glycerin-market-2392) in the treatment of conditions that result in raised eye pressure, like glaucoma, is a key factor driving the market for products containing glycerin to new heights. Elevated intraocular pressure (IOP) is frequently a symptom of glaucoma, a group of eye illnesses characterized by progressive optic nerve damage. For a number of reasons, the use of glycerin as an osmotic agent in regulating IOP has gained popularity.

Glycerin has proven to be efficient at lowering intraocular pressure, which is crucial for managing glaucoma. Glycerin can effectively lower IOP when given orally because it draws fluid out of the eye, reducing pressure that might otherwise cause optic nerve injury and vision loss. Its acceptance as a medicinal agent is being fueled by this efficacy.

Glycerin is a popular option for people with glaucoma because it is often well-tolerated by patients and has few negative effects. Glycerin is less prone than some other drugs to have systemic side effects, such as cardiovascular or respiratory problems, which can be problematic for glaucoma patients, particularly the elderly. Thus, driving the Pharmaceutical glycerin based products market revenue.

## **Pharmaceutical Glycerin Based Products Market Segment Insights**

### **Pharmaceutical glycerin based products Drug Type Insights**

The Pharmaceutical Glycerin Based Products Market segmentation, based on drug type, includes dermatological, opthalmic, cough remidies, glycerine rectal and angina. The dermatological segment dominated the market in 2022. Skin disorders are becoming more common: Eczema, [psoriasis](../../../reports/psoriasis-treatment-market-2769), acne, and dry skin are just a few of the dermatological conditions that are becoming more common. Due to its hydrating and moisturizing qualities, glycerin is a common component in dermatological products meant to treat and manage various disorders.

**Figure 1: Pharmaceutical Glycerin Based Products Market, by drug type, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Pharmaceutical glycerin based products Regional Insights**

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Pharmaceutical Glycerin Based Products Market dominated this market in 2022 (45.80%). Pharmaceutical businesses in North America create glycerin-based topical medications for ailments like eczema and psoriasis. Various solutions are designed to relieve the itch, redness, and inflammation brought on by various skin conditions. The expansion of this market sector is driven by the desire for safe and efficient treatments for persistent skin disorders. Further, the U.S.

Pharmaceutical glycerin based products market held the largest market share, and the Canada Pharmaceutical glycerin based products market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2: PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET SHARE BY REGION 2022 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe Pharmaceutical glycerin based products market accounts for the second-largest market share. Glycerin-based products that provide all-natural and mild skincare treatments are in high demand in Europe. Consumers in Europe choose goods with few ingredients and allergies, in line with the region's emphasis on skincare products that are both safe and effective. Glycerin is a preferred ingredient in these compositions because of its hydrating qualities. Further, the German Pharmaceutical glycerin based products market held the largest market share, and the UK Pharmaceutical glycerin based products market was the fastest growing market in the European region.

The Asia-Pacific Pharmaceutical Glycerin Based Products Market is expected to grow at the fastest CAGR from 2023 to 2032. Natural and herbal medicines are preferred in many Asian cultures. Since it may be made from plant sources, glycerin is appropriate for formulations that follow customs and preferences. Moreover, China’s Pharmaceutical glycerin based products market held the largest market share, and the Indian Pharmaceutical glycerin based products market was the fastest growing market in the Asia-Pacific region.

**Pharmaceutical Glycerin Based Products Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Pharmaceutical glycerin based products market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Pharmaceutical glycerin based products industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Pharmaceutical glycerin based products industry to benefit clients and increase the market sector. In recent years, the Pharmaceutical glycerin based products industry has offered some of the most significant advantages to medicine.

Major players in the Pharmaceutical glycerin based products market, including Capsugel, dupoint, AbbVie Inc, Croda International plc, Emery Oleochemicals, Johnson and Johnson, Bausch Health Companies Inc., Abbott Laboratories, Takeda Pharmaceutical Company, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd. and others, are attempting to increase market demand by investing in research and development operations.

Croda International Plc (Croda) is a chemical company that manufactures and sells specialist chemicals. Crop care, geo technology, health care, home care, industrial chemicals, lubricants, personal care, and polymer additives are a few of the industries that use the company's active ingredients and cosmetic oils in addition to coatings and polymers. It provides products to a variety of industries, including the personal care, industrial specialty, and health sciences. The company also has operations in the US, Brazil, Argentina, Sweden, Australia, South Africa, France, China, Indonesia, and other nations.

Croda's headquarters are in Goole, in the East Riding of Yorkshire, in the United Kingdom.

DuPont de Nemours Inc (DuPont), formerly known as DowDuPont Inc., is a company that provides technology-based products and solutions. It addresses both the front and back ends of the manufacturing process by offering materials and printing systems to the advanced printing industry as well as materials and solutions for the fabrication of integrated circuits and semiconductors. The company's product line includes resins, adhesives, advanced printing solutions, animal nutrition, building supplies, biomaterials, electrical solutions, textiles, fibers & nonwovens, food & beverage ingredients, industrial films, and other items.

Among the industries it helps are those in the automobile, building and construction, energy, electronics, food and beverage, textile, aerospace, medicine, personal care, and packaging and printing. DuPont's US headquarters are in Wilmington, Delaware.

**Key companies in the pharmaceutical glycerin based products market include**

**Pharmaceutical Glycerin Based Products Industry Developments**

**December 2022:** Producer of oleochemicals Oleon is investing USD 50 million in the purchase of a blending facility in Conroe, Texas. The business made improvements to its oleochemicals section, which makes glycerin.

**October 2021:** A new 110,000 metric ton (MT) per year oleochemical facility at Prai, Penang, will be built by IOI Corporation Berhad, with a capital investment of MYR 220 million. The principal raw ingredients for personal care and cosmetic products, glycerine and fatty acids based on palm and palm kernels, were the main targets of the new factory. The building of the plant is anticipated to be finished by the second quarter of 2022.

## **Pharmaceutical Glycerin Based Products Market Segmentation**

### **Pharmaceutical Glycerin Based Products Drug Type Outlook**

### **Pharmaceutical Glycerin Based Products Regional Outlook**

## Market Drivers

### Regulatory Support for Glycerin Use

The Pharmaceutical Glycerin Based Products Market benefits from favorable regulatory frameworks that support the use of glycerin in pharmaceutical applications. Regulatory bodies have recognized glycerin as a Generally Recognized As Safe (GRAS) substance, which facilitates its incorporation into various products. This regulatory endorsement not only enhances consumer confidence but also encourages manufacturers to innovate and expand their glycerin-based offerings. As a result, the market is expected to experience steady growth, with an estimated increase in glycerin-based product launches. The alignment of regulatory policies with industry needs appears to create a conducive environment for the sustained development of glycerin-based pharmaceuticals.

### Rising Prevalence of Chronic Diseases

The Pharmaceutical Glycerin Based Products Market is significantly impacted by the rising prevalence of chronic diseases, which necessitate effective treatment options. Glycerin-based products are increasingly utilized in the management of various chronic conditions, including diabetes and cardiovascular diseases. The demand for glycerin in pharmaceutical formulations is expected to rise in response to this growing health concern. Recent statistics indicate that chronic diseases account for a substantial portion of healthcare expenditures, prompting a shift towards more effective and accessible treatment solutions. This trend is likely to drive the growth of glycerin-based pharmaceuticals, as they offer a viable option for patients seeking effective management of their conditions.

### Technological Innovations in Glycerin Production

The Pharmaceutical Glycerin Based Products Market is experiencing a wave of technological innovations that enhance glycerin production processes. Advances in extraction and purification techniques have led to higher quality glycerin, which is essential for pharmaceutical applications. These innovations not only improve the efficiency of glycerin production but also reduce costs, making glycerin-based products more accessible to manufacturers. As a result, the market is likely to see an influx of new glycerin-based formulations, catering to diverse therapeutic needs. The ongoing research and development in glycerin production technologies suggest a promising future for the Pharmaceutical Glycerin Based Products Market.

### Increasing Adoption of Glycerin in Pharmaceuticals

The Pharmaceutical Glycerin Based Products Market is witnessing a notable increase in the adoption of glycerin as a key ingredient in various formulations. This trend is largely driven by glycerin's multifunctional properties, including its role as a solvent, humectant, and preservative. The versatility of glycerin allows it to be utilized in a wide range of pharmaceutical products, from topical ointments to oral solutions. Recent data indicates that glycerin-based formulations account for a substantial share of the market, with a projected growth rate of approximately 5% annually. This growth is attributed to the rising consumer preference for products that are perceived as safe and effective, further solidifying glycerin's position in the pharmaceutical landscape.

### Growing Demand for Non-Toxic and Eco-Friendly Products

The Pharmaceutical Glycerin Based Products Market is increasingly influenced by the growing consumer demand for non-toxic and environmentally friendly products. As awareness regarding the potential hazards of synthetic ingredients rises, consumers are gravitating towards natural alternatives, including glycerin. This shift is evident in the rising sales of glycerin-based formulations, which are often marketed as safer and more sustainable options. Market analysis suggests that the demand for eco-friendly pharmaceutical products is expected to grow by approximately 6% over the next five years. This trend not only reflects changing consumer preferences but also encourages manufacturers to prioritize glycerin as a key ingredient in their product lines.

## Future Outlook

The Pharmaceutical Glycerin Based Products Market is projected to grow at a 12.1% CAGR from 2025 to 2035, driven by increasing demand for natural excipients and expanding pharmaceutical applications.

**New opportunities:**

- Development of innovative glycerin-based formulations for personalized medicine. Expansion into emerging markets with tailored marketing strategies. Investment in sustainable glycerin production technologies to enhance supply chain resilience.

By 2035, the market is expected to solidify its position as a leader in [pharmaceutical excipients](https://www.marketresearchfuture.com/reports/pharmaceutical-excipients-market-868).

## Segment Insights

### By Drug Type: Dermatological (Largest) vs. Ophthalmic (Fastest-Growing)

The Pharmaceutical Glycerin Based Products Market showcases a diverse array of drug types, with dermatological applications capturing the largest share due to the increasing prevalence of skin disorders and the rising demand for topical formulations. This segment emphasizes the effectiveness of glycerin as a moisturizing agent, solidifying its importance in creams, lotions, and ointments. Meanwhile, the ophthalmic market is gaining rapid traction as consumers seek innovative solutions for eye care, particularly with the growing prevalence of conditions such as dry eye syndrome. The ease of use and safety associated with glycerin-based products have contributed to their rising popularity among healthcare practitioners and patients alike.

Dermatological (Dominant) vs. Cough Remedies (Emerging)

Dermatological products remain dominant in the Pharmaceutical Glycerin Based Products Market due to their continuous innovation in formulation and enhanced therapeutic effects that meet consumer demands. This segment often leads in market initiatives, emphasizing natural ingredients and skin health. On the other hand, cough remedies are emerging as a significant player in the market, driven by increasing respiratory ailments and a growing preference for home remedies. Glycerin's natural soothing properties make it an appealing component in cough syrups, positioning it effectively to cater to the changing consumer preferences towards more holistic and effective cough management solutions.

## Regional Market Share Analysis

### North America : Pharmaceutical Innovation Leader

North America is the largest market for pharmaceutical glycerin-based products, holding approximately 40% of the global market share. The region's growth is driven by increasing demand for pharmaceutical formulations, coupled with stringent regulatory standards that ensure product quality and safety. The presence of major pharmaceutical companies and a robust healthcare infrastructure further catalyze market expansion. The United States is the leading country in this region, with significant contributions from Canada. Key players such as Dow Inc. and BASF SE dominate the market, leveraging advanced technologies and extensive distribution networks. The competitive landscape is characterized by continuous innovation and strategic partnerships, enhancing product offerings and market reach.

### Europe : Regulatory Framework and Growth

Europe is the second-largest market for pharmaceutical glycerin-based products, accounting for approximately 30% of the global market share. The region's growth is fueled by increasing healthcare expenditures and a rising demand for high-quality pharmaceutical products. Regulatory bodies like the European Medicines Agency (EMA) play a crucial role in ensuring compliance with stringent safety and efficacy standards, which further drives market growth. Germany and France are the leading countries in this market, with a strong presence of key players such as BASF SE and Emery Oleochemicals. The competitive landscape is marked by innovation and sustainability initiatives, as companies strive to meet the evolving demands of the pharmaceutical industry. The focus on eco-friendly production methods is also gaining traction among manufacturers.

### Asia-Pacific : Emerging Market Potential

Asia-Pacific is witnessing rapid growth in the pharmaceutical glycerin-based products market, holding approximately 20% of the global market share. The region's expansion is driven by increasing healthcare access, rising disposable incomes, and a growing pharmaceutical sector. Countries like China and India are at the forefront, supported by favorable government policies and investments in healthcare infrastructure. China is the largest market in this region, followed closely by India. The competitive landscape features both local and international players, including Wilmar International and Kraton Corporation. The market is characterized by a mix of established companies and emerging startups, fostering innovation and competitive pricing strategies. This dynamic environment is expected to attract further investments and enhance market growth.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the pharmaceutical glycerin-based products market, currently holding about 10% of the global market share. The growth is primarily driven by increasing healthcare investments and a rising demand for pharmaceutical products. Countries like South Africa and the UAE are leading the way, supported by government initiatives aimed at improving healthcare access and quality. South Africa is the largest market in this region, with a growing number of local manufacturers entering the market. The competitive landscape is evolving, with key players like Vantage Specialty Chemicals expanding their presence. The region's potential for growth is significant, as more companies recognize the opportunities in this underserved market, leading to increased investments and product offerings.

## Competitive Benchmarking

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Pharmaceutical glycerin based products market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Pharmaceutical glycerin based products industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Pharmaceutical glycerin based products industry to benefit clients and increase the market sector. In recent years, the Pharmaceutical glycerin based products industry has offered some of the most significant advantages to medicine. Major players in the Pharmaceutical glycerin based products market, including Capsugel, dupoint, AbbVie Inc, Croda International plc, Emery Oleochemicals, Johnson and Johnson, Bausch Health Companies Inc., Abbott Laboratories, Takeda Pharmaceutical Company, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd. and others, are attempting to increase market demand by investing in research and development operations. Croda International Plc (Croda) is a chemical company that manufactures and sells specialist chemicals. Crop care, geo technology, health care, home care, industrial chemicals, lubricants, personal care, and polymer additives are a few of the industries that use the company's active ingredients and [cosmetic oils](https://www.marketresearchfuture.com/reports/cosmetic-oil-market-24706) in addition to coatings and polymers. It provides products to a variety of industries, including the personal care, industrial specialty, and health sciences. The company also has operations in the US, Brazil, Argentina, Sweden, Australia, South Africa, France, China, Indonesia, and other nations. Croda's headquarters are in Goole, in the East Riding of Yorkshire, in the United Kingdom. DuPont de Nemours Inc (DuPont), formerly known as DowDuPont Inc., is a company that provides technology-based products and solutions. It addresses both the front and back ends of the manufacturing process by offering materials and printing systems to the advanced printing industry as well as materials and solutions for the fabrication of integrated circuits and semiconductors. The company's product line includes resins, adhesives, advanced printing solutions, animal nutrition, building supplies, biomaterials, electrical solutions, textiles, fibers & nonwovens, food & beverage ingredients, [industrial films](https://www.marketresearchfuture.com/reports/industrial-films-market-5282), and other items. Among the industries it helps are those in the automobile, building and construction, energy, electronics, food and beverage, textile, aerospace, medicine, personal care, and packaging and printing. DuPont's US headquarters are in Wilmington, Delaware.

## Recent News & Developments

**December 2022:** Producer of oleochemicals Oleon is investing USD 50 million in the purchase of a blending facility in Conroe, Texas. The business made improvements to its oleochemicals section, which makes glycerin.

**October 2021:** A new 110,000 metric ton (MT) per year oleochemical facility at Prai, Penang, will be built by IOI Corporation Berhad, with a capital investment of MYR 220 million. The principal raw ingredients for personal care and [cosmetic products](https://www.marketresearchfuture.com/reports/cosmetic-products-market-3168), glycerine and fatty acids based on palm and palm kernels, were the main targets of the new factory. The building of the plant is anticipated to be finished by the second quarter of 2022.

## Report Scope

| MARKET SIZE 2024 | 0.2466(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 0.2765(USD Billion) |
| MARKET SIZE 2035 | 0.8665(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.1% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | BASF SE (DE), Dow Inc. (US), Glycerin Products LLC (US), Cargill, Incorporated (US), Wilmar International Limited (SG), Kraton Corporation (US), Emery Oleochemicals (MY), Vantage Specialty Chemicals, Inc. (US) |
| Segments Covered | Drug Type, Region |
| Key Market Opportunities | Growing demand for natural excipients in drug formulation enhances opportunities in the Pharmaceutical Glycerin Based Products Market. |
| Key Market Dynamics | Rising demand for pharmaceutical glycerin products driven by regulatory support and increasing consumer health awareness. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current market valuation of the Pharmaceutical Glycerin Based Products Market?**
A: As of 2024, the market valuation was 0.2466 USD Billion.

**Q: What is the projected market size for the Pharmaceutical Glycerin Based Products Market by 2035?**
A: The market is projected to reach 0.8665 USD Billion by 2035.

**Q: What is the expected CAGR for the Pharmaceutical Glycerin Based Products Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 12.1%.

**Q: Which segments are included in the Pharmaceutical Glycerin Based Products Market?**
A: Key segments include Dermatological, Ophthalmic, Cough Remedies, Glycerine Rectal, and Angina.

**Q: What was the valuation of the Dermatological segment in 2024?**
A: The Dermatological segment was valued at 0.075 USD Billion in 2024.

**Q: How much is the Cough Remedies segment projected to grow by 2035?**
A: The Cough Remedies segment is projected to grow from 0.065 USD Billion in 2024 to 0.245 USD Billion by 2035.

**Q: Who are the key players in the Pharmaceutical Glycerin Based Products Market?**
A: Key players include BASF SE, Dow Inc., Glycerin Products LLC, Cargill, Incorporated, and Wilmar International Limited.

**Q: What was the valuation of the Ophthalmic segment in 2024?**
A: The Ophthalmic segment was valued at 0.045 USD Billion in 2024.

**Q: What is the projected valuation for the Glycerine Rectal segment by 2035?**
A: The Glycerine Rectal segment is projected to reach 0.11 USD Billion by 2035.

**Q: How does the growth of the Pharmaceutical Glycerin Based Products Market compare to other pharmaceutical markets?**
A: The growth of the Pharmaceutical Glycerin Based Products Market, with a CAGR of 12.1%, indicates a robust expansion compared to many other pharmaceutical segments.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/pharmaceutical-glycerin-based-products-market-12154*